March 13, 2020 / 12:02 PM / in 22 days

BRIEF-Celon Pharma Decides On Priority Implementation Of Production Of Tests Used To Diagnose SARS-COV-2

March 13 (Reuters) - Celon Pharma SA:

* SAYS DECIDES ON PRIORITY ADOPTION OF THE BSL-3 ZONE AND IMPLEMENTATION OF PRODUCTION OF TESTS FOR QRT-PCR DIAGNOSTICS IN CO’S NEW LABORATORIES IN KAZUN NOWY

* TESTS ARE BASED ON ULTRA-FAST ONE-STEP QRT-PCR METHOD WHICH IS NOW BEING LAUNCHED IN US AND GERMANY AND ARE USED TO DIAGNOSE SARS-COV-2 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below